Reviva Pharmaceutical Holdings, Inc. (RVPH) Stock Prices Skyrocket After Success of Clinical Trial Announced
Reviva Pharmaceutical Holdings, Inc. (RVPH) stock prices were up a monumental 57.75% shortly after the trading day commenced on April 26th, 2021, bringing the price per share up to USD$6.72. What is RP5063? This news came hot on the heels of the announcement of the full details for the results of RVPH’s Phase 2 clinical […]
Vyant Bio, Inc (VYNT) Stock Prices Surge Shortly After Announcement of Three-way Collaboration
Vyant Bio, Inc (VYNT) stock prices were down 2.7% as of the end of the trading day on April 23rd, 2021, bringing the price per share down to USD$3.6 at market close. Subsequent pre-market fluctuations saw a sharp surge of 9.44% as the price of each share of VYNT went up to USD$3.94. Collaboration with […]
AeternaZentaris, Inc. (AEZS) Stock Prices Surge, Ensuring Continued Nasdaq Listing Privileges
AeternaZentaris Inc. (AEZS) stock prices were up by a marginal 0.43% as of market close on April 23rd, 2021, bringing the price per share up to USD$0.9353 at the end of the trading day. Subsequent pre-market fluctuations saw the price rise by a significant 14.40%, bringing the price per share up to USD$1.07. Collaboration with […]
Tonix Pharmaceutical Holding Corp. (TNXP) Stock Prices Lack Volatility Following OyaGen Collaboration
TonixPharaceuticals Holding Corp. (TNXP) stock prices are up 0.97% as of market close on April 23rd, 2021, bringing the price per share up to USD$1.04. Collaboration with OyaGen April 19th, 2021 saw TNXP announce their exclusive worldwide licensing agreement with OyaGen for the development of TNX-3500. The experimental COVID-19 antiviral drug is a highly promising […]
Rockwell Medical, Inc. (RMTI) Prices Soar Ahead of Data Presentation at Conference
Rockwell Medical, Inc. (RMTI) stock prices were up by a massive 15.48% shortly after the trading day commenced on April 23rd, 2021, bringing the price per share up to a comfortable USD$1.08. 2020 Revenues for RMTI RMTI reported Q4 2020 revenues of USD$ 15.2 million, as compared to USD$15.5 million for the same time period […]
9 Meters Biopharma, Inc. (NMTR) Stock Prices Trending Up Significantly Second Day in a Row
9 Meters Biopharma, Inc. (NMTR) stock prices were up 7.41% as of market close on April 22nd, 2021, bringing the share price up to USD$1.16. Subsequent pre-market fluctuation has seen the uptrend continue with a 5.09% increase, hiking the price per share up to USD$1.219. As of the start of the trading day on April […]
BioCryst Pharmaceuticals, Inc. (BCRX) Stock Price Climbs Pending 2021 Financial Reports Scheduled for May
BioCryst Pharmaceuticals, Inc. (BCRX) stock prices were up a promising 4.95% as of market close on April 21st, 2021, bringing the price per share up to USD$11.66. Subsequent pre-market fluctuations saw the stock price drop marginally by 1.46% to USD$11.49. Rampant Successes in 2020 2020 had been a blockbuster year for BCRX, as indicated by […]
Catabasis Pharmaceuticals, Inc. (CATB) Stock Price Trending Upwards Following Developments
Catabasis Pharmaceuticals, Inc. (CATB) stock prices enjoyed an 8.48% uptrend as of market close on April 19th, 2021, settling into a price of USD$2.43 per share. Subsequent pre-market fluctuations saw CATB stock prices climb further to hit UDS$2.44, a 0.41% increase. CATB Acquires Quellis In January 2021, Quellis Biosciences Inc. was acquired by CATB in […]
Ocugen, Inc (OCGN) Stock Price Continue to Stumble Amidst IP Uncertainty
Ocugen, Inc. (OCGN) stock prices were down 6.02% as of market close on April 16th, 2021, settling in at USD$5.78. Subsequent pre-market fluctuation saw a dip to USD$5.30, a drop of 7.09%. Ocugen and Bharat Biotech Collaborate In December of 2020, Ocugen announced its collaboration with the India-based Bharat Biotech to facilitate the development of […]
Traverna Inc. (TRVN) Stock Price Skyrocket After OLINVYK Developments
Traverna Inc. (TRVN) stock prices surged an astounding 31.58% on April 15th, 2021, coming to a market close price of USD$2.25. Subsequent pre-market fluctuations saw a 4.89% dip to bring the price of TRVN shares to USD$2.14. The dip is most likely a result of investors cashing out from the monumental gains for fear of […]
